RBMS1

Across TCGA pan-cancer cohorts, RBMS1 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated RBMS1 data layer compared with 27 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RBMS1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RBMS1 expression acts as an unfavorable survival marker.

HNSC, CCRCC, and GBM are the cancer types where RBMS1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	IV	0.727	0.925	.015	9	view →
CCRCC	DFS	Quartile	All	0.743	0.968	.007	8	view →
GBM	DFS	Median	All	0.673	0.818	.022	7	view →
LUAD	OS	Quartile	II,III,IV	0.292	1.000	.012	6	view →
UCEC	OS	Tertile	II,III,IV	0.569	1.000	.031	4	view →
PDAC	OS	Median	III,IV	0.322	0.555	.035	4	view →
LSCC	DFS	Quartile	All	0.711	0.932	.010	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RBMS1–HNSC (OS)

Open the HNSC breakdown →